Steven F S, Johnson J, Eason P
Department of Biochemistry and Molecular Biology, School of Biological Sciences, University of Manchester, UK.
Anticancer Res. 1993 Jul-Aug;13(4):1059-61.
Hela cells originate from a clone of cervical carcinoma cells. The cytoplasm of Hela cells contains a protein which recognises and inhibits a proteolytic enzyme (guanidino-benzoatase) on the surface of Hela cells. This same protease is present on the surface of abnormal epithelial cells obtained from cervical smears, enabling a rhodamine labelled inhibitor extracted from Hela cells to locate abnormal cervical cells in monolayer spreads.
海拉细胞源自宫颈癌细胞的一个克隆。海拉细胞的细胞质含有一种蛋白质,该蛋白质能识别并抑制海拉细胞表面的一种蛋白水解酶(胍基苯甲酰酶)。从宫颈涂片获得的异常上皮细胞表面也存在同样的蛋白酶,这使得从海拉细胞中提取的一种罗丹明标记抑制剂能够在单层铺片中定位异常宫颈细胞。